Congratulations Professor Lu on your May 2026 Promotion!
Weining Lu, MD, MS, Medicine/Nephrology, is a physician-scientist focused on studies of kidney and urinary tract development, disease and novel therapeutics. He has served as the lead academic PI in a highly productive collaboration with Pfizer to develop therapies targeting the SLIT/ROBO pathway. This academic–industry collaboration led to an international multicenter Phase 2 clinical trial and the first licensing agreement between Pfizer and BU/BMC. In recognition of this work, Dr. Lu was named the University’s 2019 Innovator of the Year, an award honoring faculty who translate world-class research into inventions and innovations that benefit humankind. Dr. Lu is chair of the Core Oversight Advisory Committee in the department of medicine, co-director of the BU Clinical & Translational Science Institute R01 Proposal Writing Workshop, lead director of the BU Biomedical Innovation Technologies Affinity Research Collaboratives and the B4D-ARC program, and a voting member of the BU Institutional Biosafety Committee. He is a fellow of the American Society of Nephrology and the International Society of Nephrology, a professional member of the American Heart Association, an academic editor for PLOS ONE, and a member of NIH grant review study sections.